These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 15124013)

  • 41. Iron and inflammation: cross-talk between pathways regulating hepcidin.
    Fleming RE
    J Mol Med (Berl); 2008 May; 86(5):491-4. PubMed ID: 18425494
    [No Abstract]   [Full Text] [Related]  

  • 42. Hepcidin in anemia and inflammation in chronic kidney disease.
    Malyszko J; Mysliwiec M
    Kidney Blood Press Res; 2007; 30(1):15-30. PubMed ID: 17215586
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of IL-22 contribution to hepcidin induction and hypoferremia during the response to LPS in vivo.
    Wallace DF; Subramaniam VN
    Int Immunol; 2015 Jun; 27(6):281-7. PubMed ID: 25568302
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations.
    Valenti L; Dongiovanni P; Motta BM; Swinkels DW; Bonara P; Rametta R; Burdick L; Frugoni C; Fracanzani AL; Fargion S
    Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):683-90. PubMed ID: 21183736
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production.
    Hashizume M; Uchiyama Y; Horai N; Tomosugi N; Mihara M
    Rheumatol Int; 2010 May; 30(7):917-23. PubMed ID: 19639319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepcidin is linked to anemia and inflammation in peritoneal dialysis patients.
    Malyszko J; Malyszko JS; Pawlak K; Drozdowska-Rams L; Brzosko S; Mysliwiec M
    Perit Dial Int; 2008; 28(4):418-21. PubMed ID: 18556388
    [No Abstract]   [Full Text] [Related]  

  • 47. Iron imports. IV. Hepcidin and regulation of body iron metabolism.
    Ganz T; Nemeth E
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G199-203. PubMed ID: 16407589
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [An iron regulator hepcidin is affected by EPO].
    Sun XF; Zhou DB; Zhao YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):778-82. PubMed ID: 16928320
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression.
    Wang RH; Li C; Xu X; Zheng Y; Xiao C; Zerfas P; Cooperman S; Eckhaus M; Rouault T; Mishra L; Deng CX
    Cell Metab; 2005 Dec; 2(6):399-409. PubMed ID: 16330325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Repression of repulsive guidance molecule C during inflammation is independent of Hfe and involves tumor necrosis factor-alpha.
    Constante M; Wang D; Raymond VA; Bilodeau M; Santos MM
    Am J Pathol; 2007 Feb; 170(2):497-504. PubMed ID: 17255318
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pro-inflammatory cytokine interleukin-6-induced hepcidin, a key mediator of periodontitis-related anemia of inflammation.
    Han Y; Huang W; Meng H; Zhan Y; Hou J
    J Periodontal Res; 2021 Aug; 56(4):690-701. PubMed ID: 33656216
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [New insights on hepcidin in anemia of chronic disease].
    Wang FD; Zhou DB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1616-8. PubMed ID: 20030959
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pathogenesis of the anaemia of chronic disorders.
    Manzini CU; Manzini E; Ferri C
    Reumatismo; 2012 Jul; 64(3):128-33. PubMed ID: 22842295
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anemia of chronic disease: illness or adaptive mechanism.
    Županić-Krmek ; Sučić M; Bekić D
    Acta Clin Croat; 2014 Sep; 53(3):348-54. PubMed ID: 25509246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Disturbed iron balance in hemochromatosis and inflammation. Discovery of iron-regulating hormone hepcidin gives new explanations].
    Stål P; Gåfvels M; Eggertsen G; Holmström P
    Lakartidningen; 2007 May 30-Jun 3; 104(22):1696-700. PubMed ID: 17601319
    [No Abstract]   [Full Text] [Related]  

  • 56. Inflammation-induced hepcidin-25 is associated with the development of anemia in septic patients: an observational study.
    van Eijk LT; Kroot JJ; Tromp M; van der Hoeven JG; Swinkels DW; Pickkers P
    Crit Care; 2011; 15(1):R9. PubMed ID: 21219610
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of DS42450411 as a potent orally active hepcidin production inhibitor: Design and optimization of novel 4-aminopyrimidine derivatives.
    Fukuda T; Ishiyama T; Katagiri T; Ueda K; Muramatsu S; Hashimoto M; Aki A; Baba D; Watanabe K; Tanaka N
    Bioorg Med Chem Lett; 2018 Nov; 28(20):3333-3337. PubMed ID: 30217414
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo imaging of hepcidin promoter stimulation by iron and inflammation.
    Flanagan JM; Truksa J; Peng H; Lee P; Beutler E
    Blood Cells Mol Dis; 2007; 38(3):253-7. PubMed ID: 17331760
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IL-22 regulates iron availability in vivo through the induction of hepcidin.
    Smith CL; Arvedson TL; Cooke KS; Dickmann LJ; Forte C; Li H; Merriam KL; Perry VK; Tran L; Rottman JB; Maxwell JR
    J Immunol; 2013 Aug; 191(4):1845-55. PubMed ID: 23836059
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patterns of hepatic iron distribution in patients with chronically transfused thalassemia and sickle cell disease.
    Ghugre NR; Gonzalez-Gomez I; Butensky E; Noetzli L; Fischer R; Williams R; Harmatz P; Coates TD; Wood JC
    Am J Hematol; 2009 Aug; 84(8):480-3. PubMed ID: 19536851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.